Reviewing Revvity (NYSE:RVTY) & Ryman Healthcare (OTCMKTS:RYHTY)

Ryman Healthcare (OTCMKTS:RYHTY) and Revvity (NYSE:RVTY) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, profitability and dividends.

Insider and Institutional Ownership

86.7% of Revvity shares are held by institutional investors. 0.7% of Revvity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Ryman Healthcare and Revvity”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ryman Healthcare	$451.64 million	N/A	-$259.39 million	N/A	N/A
Revvity	$2.86 billion	3.81	$241.20 million	$2.08	46.16

Revvity has higher revenue and earnings than Ryman Healthcare.

Profitability

This table compares Ryman Healthcare and Revvity’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ryman Healthcare	N/A	N/A	N/A
Revvity	8.45%	7.92%	4.81%

Analyst Ratings

This is a summary of recent recommendations and price targets for Ryman Healthcare and Revvity, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ryman Healthcare	0	0	0	0	0.00
Revvity	1	8	5	0	2.29

Revvity has a consensus target price of $113.67, indicating a potential upside of 18.39%. Given Revvity’s stronger consensus rating and higher possible upside, analysts clearly believe Revvity is more favorable than Ryman Healthcare.

Risk & Volatility

Ryman Healthcare has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500. Comparatively, Revvity has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500.

Summary

Revvity beats Ryman Healthcare on 11 of the 11 factors compared between the two stocks.

About Ryman Healthcare

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hair salons, library, dining area, bar, lounges, croquet laws, shops, and movie theatre facilities. The company owns and operates retirement village units and care units. The company was founded in 1984 and is based in Christchurch, New Zealand.

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.